ROSUVASOME Trademark

Trademark Overview


On Monday, November 25, 2024, a trademark application was filed for ROSUVASOME with the United States Patent and Trademark Office. The USPTO has given the ROSUVASOME trademark a serial number of 79416329. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, December 9, 2025. This trademark is owned by BEIJING INNO MEDICINE CO., LTD.. The ROSUVASOME trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; medical cardiovascular pharmaceuticals; cardiovascular pharmaceuticals; pharmaceuticals for the treatment of cardiovascular and cerebrovascular diseases; capsules sold empty for medicines; pharmaceutical preparations for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; pharmaceuticals for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; ointments for pharmaceutical purposes, namely, antibiotic ointments, anti-inflammatory ointment; biolo...
rosuvasome

General Information


Serial Number79416329
Word MarkROSUVASOME
Filing DateMonday, November 25, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, December 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicines for human purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; medical cardiovascular pharmaceuticals; cardiovascular pharmaceuticals; pharmaceuticals for the treatment of cardiovascular and cerebrovascular diseases; capsules sold empty for medicines; pharmaceutical preparations for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; pharmaceuticals for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; ointments for pharmaceutical purposes, namely, antibiotic ointments, anti-inflammatory ointment; biological preparations for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; chemical preparations for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 6, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBEIJING INNO MEDICINE CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, February 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, February 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 8, 2025APPLICATION FILING RECEIPT MAILED
Friday, May 16, 2025ASSIGNED TO EXAMINER
Friday, May 23, 2025NON-FINAL ACTION WRITTEN
Saturday, May 24, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 16, 2025REFUSAL PROCESSED BY MPU
Thursday, July 17, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 2, 2025REFUSAL PROCESSED BY IB
Tuesday, December 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED